CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Cyclosporin A Restasis® +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00565669
NCT00565669N/ACompleted
CompareCT.gov

Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye Symptoms

Medical University of South Carolina·interventional·Posted Nov 30, 2007·Updated Nov 7, 2018

In Brief

A clinical study evaluating Cyclosporin A Restasis®, Blink tears, and 1 other intervention for Dry Eye Syndrome. Completed, enrolled 20 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the efficacy of Blink Tears and Systane used concomitantly with topical cyclosporine for the treatment of dry eye.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye Syndrome
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 30, 2007
Enrollment StartOct 1, 2007
Primary CompletionOct 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 18.6 years ago

Interventions

Cyclosporin A Restasis®drug

Blink tearsdrug

blink tears to be used twice a day

Systanedrug

systane to be used twice a day